Shanghai Haoyuan Chemexpress Co.Ltd(688131) : the trading of 100% equity shares of drug source drugs to be purchased is suspended

Shanghai Haoyuan Chemexpress Co.Ltd(688131) announced on February 18 that Shanghai Haoyuan Chemexpress Co.Ltd(688131) is planning to issue shares and pay cash to buy assets and raise supporting funds. It will not lead to the change of the actual controller of the company. In view of the fact that this transaction intends to issue shares to Shanghai Anshu Information Technology Co., Ltd., the controlling shareholder of the company, to raise supporting funds, this transaction constitutes a connected transaction. Due to the uncertainty of relevant matters, in order to ensure fair information disclosure, safeguard the interests of investors and avoid significant impact on the company’s share price, the trading of the company’s shares will be suspended from the opening of the market on Monday, February 21, 2022 upon the application of the company, which is expected to be suspended for no more than 10 trading days.

From January to June 2021, Shanghai Haoyuan Chemexpress Co.Ltd(688131) ‘s operating revenue composition is: molecular block and tool compound product sales account for 47.44%, API and intermediate development business product sales account for 38.16%, API and intermediate development business technical services account for 8.38%, molecular block and tool compound technical services account for 5.36%, and other businesses account for 0.66%.

- Advertisment -